Taketoshi Kushida

Taketoshi Kushida

Auto-generated profile, based on publicly available information

Taketoshi Kushida

Department of Orthopedic Surgery, Kansai Medical University, 10‐15 Fumizono‐cho, Moriguchi‐City, Osaka 570‐8506, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
NONaofumi Okamoto
Naofumi Okamoto
TKTaketoshi Kushida
Taketoshi Kushida
KOKenichi Oe
Kenichi Oe
MUMasayuki Umeda
Masayuki Umeda
SISusumu Ikeahra
Susumu Ikeahra
HIHirokazu Iida
Hirokazu Iida
Les tendon ruptures in a rat model with transplantation of whole bone marrow cells. Methods: Nine F344/Nslc (Fisher) rats were the source of bone marrow cells and mesenchymal stem cells as well as normal Achilles tendons. Eighty-seven Fisher rats were used for the experiments. The rats were divided into three groups: the BMC group (bone marrow cells injected around the tendon), the MSC group (mesenchymal stem cells injected around the tendon), and the non-treated control group (incision only). Outcome measures included mechanical testing, collagen immunohistochemistry, histological analysis, and reverse transcription-polymerase chain reaction to detect expression of transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF). Results: The ultimate failure load in the BMC group was significantly greater than that in the non-treated or the MSC group at seven days after incision (3.8 N vs. 0.9 N or 2.1 N, p < 0.016) and at fourteen days after incision (10.2 N vs. 6.1 N or 8.2 N, p < 0.016). The ultimate failure load in the BMC group at twenty-eight days after incision (33.8 N) was the same as that of normal tendon (34.8 N). The BMC group demonstrated stronger staining for type-III collagen at seven days after incision and stronger staining for type-I collagen at twenty-eight days than did the MSC group. Expression of TGF-β and VEGF in the BMC group was significantly increased compared with that in the other groups at four days after incision (TGF-β: 1.6 vs. 1.3 or 0.6, p < 0.01; VEGF: 1.7 vs. 1.1 or 0.9, p < 0.01). Conclusions: Transplantation of whole bone marrow cells may be a better and more readily available treatment for Achilles tendon rupture than cultured mesenchymal stem cells. Clinical Relevance: The present study provides evidence that transplantation of bone marrow cells may be a promising therapy for the treatment of Achilles tendon rupture....

1 November 2000 in Stem Cells
Verified
Journal Article
Open access
PDF file
TKTaketoshi Kushida
Taketoshi Kushida
MIMuneo Inaba
Muneo Inaba
KIKazuya Ikebukuro
Kazuya Ikebukuro
TNTakashi Ngahama
Takashi Ngahama
HOHaruki Oyaizu
Haruki Oyaizu
SISusumu Ikeahra
Susumu Ikeahra
To minimize contamination of bone marrow cells (BMCs) with T cells from the peripheral blood, a new “perfusion method” for collecting BMCs is proposed using cynomolgus monkeys. Two BM puncture needles are inserted into a long bone such as the humerus, femur, or tibia. One needle is connected to an extension tube and the end of the tube is inserted into a culture flask to collect the BM fluid. The other needle is connected to a syringe containing 30 ml of phosphate‐buffered saline. The solution is pushed gently from the syringe into the medullary cavity, and the medium containing the BM fluid is collected into the culture flask. There is significantly less contamination with peripheral blood, determined from the frequencies of CD4+ and CD8+ T cells, when using this method (20%) consisting of multiple BM aspirations from the iliac crest. Furthermore, the number and progenitor activities of the cells harvested using this “perfusion method” are greater than those harvested using the conventional aspiration method. This perfusion method was carried out 42 times using 15 cynomolgus monkeys, and no complications such as pulmonary infarction or paralysis were observed. These findings suggest that the “perfusion method” is safe and simple and would be of great advantage in obtaining pure BMCs, resulting in a less frequent occurrence of acute graft‐versus‐host‐disease in allogeneic BM transplantation.

27 August 2008 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
MUMasayuki Umeda
Masayuki Umeda
TKTaketoshi Kushida
Taketoshi Kushida
KSKunihiko Sasai
Kunihiko Sasai
TATaku Asada
Taku Asada
KOKenichi Oe
Kenichi Oe
HIHirokazu Iida
Hirokazu Iida

22 February 2008 in Modern Rheumatology
Verified
Journal Article
Closed access
HMHiroyuki Matsuya
Hiroyuki Matsuya
TKTaketoshi Kushida
Taketoshi Kushida
TATaku Asada
Taku Asada
MUMasayuki Umeda
Masayuki Umeda
TWTakahiko Wada
Takahiko Wada
HIHirokazu Iida
Hirokazu Iida
Osteonecrosis (ON) of the femoral head is one of the most serious complications associated with steroid administration. Here, we treated corticosteroid-induced ON in the rabbit by transplanting mesenchymal cells (MCs). Rabbits were injected once with 20 mg/kg of methylprednisolone (MPSL) and divided into three groups as follows: (1) MPSL alone (no further treatment); (2) MPSL+MCs (7 days after MPSL, MCs [1 × 107/2 ml] were injected into the bone marrow cavity of the femurs); (3) MPSL+saline (7 days after MPSL, saline [2 ml] was injected into the bone marrow cavity of the femurs). Subsequently, the incidence of ON in the femurs 4 weeks after MPSL alone and MPSL+saline was 80 and 68.4%, respectively. In contrast, no ON was recorded in rabbits treated with MPSL+MCs. Vascular endothelial growth factor (VEGF) staining and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) nick end-labeling (TUNEL) staining was more marked in the MPSL alone and MPSL+saline groups than in the MPSL+MCs rabbits. The percentages of cells in the G1 phase in the MPSL+MCs group were significantly lower than in the other two groups. These findings suggest that the injection of autologous MCs into the femur could prevent corticosteroid-induced ON in patients treated with high-dose short-term steroid medication.

1 January 2002 in The Journal of Kansai Medical University
Verified
Journal Article
Closed access
TKTaketoshi Kushida
Taketoshi Kushida
MIMuneo Inaba
Muneo Inaba
HHHiroko Hisha
Hiroko Hisha
NINaoya Ichioka
Naoya Ichioka
TETakashi Esumi
Takashi Esumi
SISusumu Ikeahra
Susumu Ikeahra